| Zeit | Aktuelle Nachrichten
| | Leser | Medien |
|---|
| 25.05.
| Dr Reddys Laboratories Bullish Moving Average Crossover Alert | | - | SmarTrend |
| 25.05.
| Dr. Reddy's Laboratories Should Continue To Gain Market Share In Lucrative Markets | | - | Seeking Alpha |
| 23.05.
| Stocks in News: Dr Reddy, Apollo Tyres, NTPC... | | - | Myiris |
| 22.05.
| The Zacks Analyst Blog Highlights: Mylan, Bristol-Myers Squibb, Sanofi, Teva Pharmaceuticals and Dr. Reddy's Laboratories | | 76 | PR Newswire |
| CHICAGO, May 22, 2012 /PRNewswire/ -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events...
Mehr lesen zu:
The Zacks Analyst Blog Highlights: Mylan, Bristol-Myers Squibb, Sanofi, Teva Pharmaceuticals and Dr. Reddy's Laboratories | |
| 22.05.
| Genpact Signs Business Process Management Engagement with Dr. Reddy's Laboratories | | 56 | PR Newswire |
| NEW YORK, May 22, 2012 /PRNewswire/ --Genpact Limited (NYSE: G), a global leader in business process and technology management, today announced that it has signed an agreement with Dr. Reddy's Laboratories...
Mehr lesen zu:
Genpact Signs Business Process Management Engagement with Dr. Reddy's Laboratories | |
| 21.05.
| The Zacks Analyst Blog Highlights: Dr. Reddy's Laboratories, Bristol-Myers Squibb, Teva Pharmaceutical, Biogen Idec and Elan | | 56 | PR Newswire |
| CHICAGO, May 21, 2012 /PRNewswire/ -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting...
Mehr lesen zu:
The Zacks Analyst Blog Highlights: Dr. Reddy's Laboratories, Bristol-Myers Squibb, Teva Pharmaceutical, Biogen Idec and Elan | |
| 21.05.
| From Earlier: Dr. Reddy's Announces the Launch of Over-the-Counter Lansoprazole Delayed-Release Capsules | | - | Benzinga.com |
| 21.05.
| Dr. Reddy's Labs (RDY) Launches Generic OTC Prevacid (NVS) | | - | StreetInsider.com |
| 21.05.
| Dr Reddy's introduces generic version of Plavix in US | | - | Pharma Bus Review |
| 21.05.
| Dr Reddy's launches OTC Lansoprazole delayed-release capsules | | - | Myiris |
| 21.05.
| Dr. Reddy's Announces the Launch of Over-the-Counter Lansoprazole Delayed-Release Capsules | | 81 | Business Wire |
| Dr. Reddy's Laboratories (NYSE: RDY) announced today that it has
launched over-the-counter (OTC) Lansoprazole delayed-release capsules in
the U.S. market on May 18, 2012...
Mehr lesen zu:
Dr. Reddy's Announces the Launch of Over-the-Counter Lansoprazole Delayed-Release Capsules | |
| 18.05.
| Dr. Reddy's Launches Plavix' Generic | | - | Zacks |
| 18.05.
| Dr. Reddy's Labs (RDY) Launches Generic Plavix Tabs (SNY) | | - | StreetInsider.com |
| 18.05.
| Dr Reddy launches Clopidogrel tablets in US market | | - | moneycontrol.com |
| 18.05.
| Dr Reddy's, Aurobindo get US nod for generic cardiac drug | | - | moneycontrol.com |
| 18.05.
| Dr Reddy's launches Clopidogrel tablets in US | | 1 | Myiris |
| 18.05.
| Dr. Reddy's Announces the Launch of Clopidogrel Tablets, USP | | 103 | Business Wire |
| Dr. Reddy's Laboratories (NYSE: RDY) announced today that it has
launched CLOPIDOGREL TABLETS, USP
75 mg & 300 mg, a
bioequivalent generic version of PLAVIX®, in...
Mehr lesen zu:
Dr. Reddy's Announces the Launch of Clopidogrel Tablets, USP | |
| 15.05.
| Upgrade Alert for Dr Reddys Laboratories | | - | SmarTrend |
| 14.05.
| Generics Drive Dr. Reddy's | | 3 | Zacks |
| 14.05.
| Dr. Reddy's Laboratories zahlt 22 Prozent mehr Dividende | | 5 | MyDividends.de |
